ConductScience.org, home

Gene · 3594

Papers2,084

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

241 to 260 of 2,084

Download this page as JSON
TitleJournalYearPMIDFound bySource
[Analysis of IFN-γR1 (CD119) and IL-12Rβ1 (CD212) Deficiency by Flow Cytometry].Mikrobiyol Bul202336636848PubTator, text miningPubMed
Mendelian Susceptibility to Mycobacterial Disease (MSMD): Clinical, Immunological, and Genetic Features of 22 Patients from 15 Moroccan Kindreds.J Clin Immunol202336630059PubTator, text miningPubMed
Immune responses to human fungal pathogens and therapeutic prospects.Nat Rev Immunol202336600071PubTator, text miningPubMed
Use of NanoBiT and NanoBRET to characterise interleukin-23 receptor dimer formation in living cells.Br J Pharmacol202336560872PubTator, text miningPubMed
Impact of SARS-CoV-2 infection and COVID-19 on patients with inborn errors of immunity.J Allergy Clin Immunol202336522221PubTator, text miningPubMed
Comparison of Pharmacokinetic Similarity, Immunogenicity, and Safety of Ustekinumab and BAT2206 in Healthy Chinese Male Subjects in a Double-Blind, Randomized, Single-Dose, Parallel-Group Phase I Trial.
BioDrugs202336417156PubTator, text miningPubMed
Biomarkers associated with the development of comorbidities in patients with atopic dermatitis: A systematic review.Allergy202336366871PubTator, text miningPubMed
Association between gene polymorphisms of IL-12, IL-12 receptor and IL-27 and organ involvement in Iranian endometriosis patients.Int J Immunogenet202336328955PubTator, text miningPubMed
Inherited human ITK deficiency impairs IFN-γ immunity and underlies tuberculosis.J Exp Med202336326697PubTator, text miningPubMed
First-in-human study of deucravacitinib: A selective, potent, allosteric small-molecule inhibitor of tyrosine kinase 2.Clin Transl Sci202336325947PubTator, text miningPubMed
Mendelian Susceptibility to Mycobacterial Disease: Retrospective Clinical and Genetic Study in Mexico.J Clin Immunol202336044171PubTator, text miningPubMed
Distinct blood protein profiles associated with the risk of short-term and mid/long-term clinical relapse in patients with Crohn's disease stopping infliximab: when the remission state hides different types of residual disease activity.
Gut202336008101PubTator, text miningPubMed
Maternal plasma cytokines and the subsequent risk of uterine atony and postpartum hemorrhage.J Perinat Med202335724639PubTator, text miningPubMed
Differential epitranscriptome and proteome modulation in the brain of neonatal mice exposed to isoflurane or sevoflurane.Cell Biol Toxicol202335249202PubTator, text miningPubMed
Eight years of follow-up experience in children with mendelian susceptibility to mycobacterial disease and review of the literature.Asian Pac J Allergy Immunol202333638623PubTator, text miningPubMed
Effectiveness and Durability of Ustekinumab Therapy With or Without Immunomodulators for Ulcerative Colitis Patients in Japan.Crohns Colitis 360202236777045PubTator, text miningPubMed
Etiopathogenesis of Psoriasis from Genetic Perspective: An updated Review.Curr Genomics202236777004PubTator, text miningPubMed
ABI3BP is a prognosis biomarker related with clinicopathological features and immunity infiltration of lung tumor.Front Genet202236744181PubTator, text miningPubMed
HLA and Non-HLA gene polymorphisms in autoimmune hepatitis patients of North Indian adults.Front Immunol202236741403PubTator, text miningPubMed
Polyvalent human immunoglobulin for infectious diseases: Potential to circumvent antimicrobial resistance.Front Immunol202236713426PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3594/papers?page=13